These final results, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the concept of focusing on ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Diseases. At times I https://robertz849ofu5.targetblogs.com/profile